Use access key #2 to skip to page content.
$41.72 -0.97 (-2.27%)
5/16/2008 4:00 PM

ImClone Systems, Inc. (IMCL)

CAPS Rating:
***

A biopharmaceutical company which advances oncology care by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients with a variety of cancers.

View All Commentary (IMCL)

Recs

0

Avatar evillate (83.43) Submitted: 5/01/08 6:44 PM : Outperform Start Price: $48.18 IMCL Score: -14.42

Competitors drug showed that it did not help. I'll ride that for a little while.

Report this Post Replies: 0 | Reply

Featured Broker Partners